IM Cannabis (IMCC) Tax Provisions (2020 - 2025)
IM Cannabis' (IMCC) quarterly Tax Provisions came in at $4302.5 in Q4 2025, up 112.79% year-on-year from $2022.0 in Q4 2024, and down 95.8% quarter-over-quarter from $102455.5 in Q3 2025.
IM Cannabis (IMCC) Tax Provisions (2020 - 2025) Analysis & Trends
IM Cannabis' Tax Provisions history runs 6 years deep, the most recent figure standing at $4302.5 for Q4 2025.
- On a quarterly basis, Tax Provisions rose 112.79% year-over-year to $4302.5 in Q4 2025; TTM through Dec 2025 was $52183.5, a 138.22% increase from a year earlier, with the FY2025 full-year figure at $65971.9, up 108.83% from the prior year.
- Tax Provisions fell to $4302.5 in Q4 2025 per IMCC's latest filing, from $102455.5 in the prior quarter.
- Across five years, Tax Provisions topped out at $529600.1 in Q4 2023 and bottomed at -$924737.6 in Q2 2022.
- The 5-year median for Tax Provisions is -$19792.9 (2024), against an average of -$38604.0.
- Across the five-year window, Tax Provisions plunged 3172.17% in 2022 and jumped 759.52% in 2023, its largest moves.
- Year by year, Tax Provisions stood at $233240.8 in 2021, then sank by 134.43% to -$80300.6 in 2022, then soared by 759.52% to $529600.1 in 2023, then sank by 106.35% to -$33644.9 in 2024, then surged by 112.79% to $4302.5 in 2025.
- Per Business Quant, the three latest IMCC Tax Provisions figures stand at $4302.5 (Q4 2025), $102455.5 (Q3 2025), and -$20929.7 (Q2 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 67.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 157.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 676.90 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 43.40 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -423.70 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 48.90 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 30.00 Mn |
| 10 | IM Cannabis | 591,792.44 | -193,562.09 | 1.03 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 4,302.52 |
| Sep 30, 2025 | 102,455.54 |
| Jun 30, 2025 | -20,929.66 |
| Dec 31, 2024 | -33,644.91 |
| Sep 30, 2024 | -19,059.39 |
| Jun 30, 2024 | -613,426.92 |
| Dec 31, 2023 | 529,600.12 |
| Sep 30, 2023 | -93,241.31 |
| Dec 31, 2022 | -80,300.62 |
| Sep 30, 2022 | 156,416.23 |
| Jun 30, 2022 | -924,737.63 |
| Mar 31, 2022 | -20,526.36 |
| Dec 31, 2021 | 233,240.81 |
| Sep 30, 2021 | -265,332.71 |
| Jun 30, 2021 | 30,100.50 |
| Mar 31, 2021 | 397,419.86 |
| Dec 31, 2020 | -505,489.02 |
| Sep 30, 2020 | -167,344.48 |
| Jun 30, 2020 | -26,684.55 |
| Mar 31, 2020 | -880,901.51 |